KP Tissue Inc. saw a significant drop in its stock price, closing down 2.87% in the last trading session.
In yesterday's trading session, KP Tissue Inc. (KPT.TO) experienced a notable decline, closing at CA$13.22. This drop raises questions about the factors contributing to this downturn for the company, which has been navigating a challenging market environment.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$129.36M
P/E
14.3x
Div. yield
5.56%
Div. / share
$0.72
52W high
$13.61
52W low
$8.68
1W change
-0.93%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.6% Upside
Current Price
C$12.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
15.6%
Annualized
90-Day Vol
16.1%
Annualized
Trend (90d)
+48.6%
Annualized drift
90d Mean
C$15.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.56 | C$12.85 – C$14.31 |
| 60 trading days | C$14.37 | C$13.32 – C$15.51 |
| 90 trading days | C$15.23 | C$13.87 – C$16.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor KP Tissue's financial performance and market conditions, especially given the recent decline in stock value.
KP Tissue Inc. experiences a 2.87% decline in one day.
With a market cap of CA$132.57 million, KP Tissue's stock performance is under scrutiny as investors weigh the implications of its recent downturn.
Bull case
Despite the recent drop, KP Tissue has a solid market cap of CA$132.57 million and a reasonable P/E ratio of 14.69. This suggests there could be potential for recovery if market conditions improve.
Bear case
However, the lack of recent news or catalysts to support the stock raises concerns. This might mean the decline could continue, especially if broader market trends remain unfavorable for the sector.
Recent Performance Overview
Advertisement
KP Tissue Inc. closed at CA$13.22, reflecting a 2.87% decrease in its stock price. This decline is significant for investors, particularly considering the company's market cap of CA$132.57 million. The stock's performance has been under pressure, and the absence of recent news may have contributed to investor uncertainty.
Market Sentiment and Future Outlook
The lack of recent developments or positive news surrounding KP Tissue raises concerns about its future performance. Investors are advised to keep an eye on upcoming financial results and market trends that could impact the stock. With a P/E ratio of 14.69, there may still be potential for recovery, but caution is warranted.
What Investors Should Consider
As KP Tissue navigates this downturn, investors should evaluate their positions carefully. The company's dividend yield of 5.37% may provide some cushion, but the current profit margin of 0% indicates challenges ahead. Keeping track of the company's financial health and market conditions will be crucial for making informed investment decisions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
